Document is current
Any future updates will be listed below
-
Authors
Kim, Daniel Y.
Behbahani, Sara
Moncayo, Alejandra
Trepanowski, Nicole
Hartman, Rebecca I.
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH2110819)
U.S. Department of Veterans Affairs (VA CSR&D CX-002531)
- License Information
-
More Information
Article History
Received: 3 April 2024
Revised: 3 April 2024
Accepted: 26 April 2024
First Online: 8 June 2024
Declarations
:
: Mr. Kim is a paid consultant at Verve Therapeutics and SeQure Dx, unrelated to this research. Dr. Hartman is a scientific officer for Evereden, unrelated to this research. Mr. Kim and Dr. Hartman’s interests were reviewed and are managed by Mass General Brigham in accordance with their conflict-of-interest policies.
: IRB approval was not required due to the use of deidentified and publicly available data.
